Fluorine in PDB 6fs8: Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa)
Protein crystallography data
The structure of Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa), PDB code: 6fs8
was solved by
S.Cusack,
V.Speranzini,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
59.86 /
1.80
|
Space group
|
P 43
|
Cell size a, b, c (Å), α, β, γ (°)
|
59.820,
59.820,
125.890,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.3 /
21.5
|
Other elements in 6fs8:
The structure of Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa) also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa)
(pdb code 6fs8). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa), PDB code: 6fs8:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 6fs8
Go back to
Fluorine Binding Sites List in 6fs8
Fluorine binding site 1 out
of 4 in the Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F201
b:26.8
occ:1.00
|
F2
|
B:E4Z201
|
0.0
|
26.8
|
1.0
|
C23
|
B:E4Z201
|
1.3
|
23.8
|
1.0
|
C24
|
B:E4Z201
|
2.3
|
23.6
|
1.0
|
C22
|
B:E4Z201
|
2.4
|
24.1
|
1.0
|
F1
|
B:E4Z201
|
2.6
|
24.1
|
1.0
|
CB
|
B:PHE24
|
3.0
|
24.5
|
1.0
|
CG
|
B:GLU26
|
3.4
|
33.2
|
1.0
|
CG
|
B:PHE24
|
3.5
|
24.2
|
1.0
|
C13
|
B:E4Z201
|
3.6
|
21.9
|
1.0
|
C21
|
B:E4Z201
|
3.6
|
23.6
|
1.0
|
SD
|
B:MET34
|
3.7
|
28.2
|
1.0
|
CD2
|
B:PHE24
|
4.0
|
25.8
|
1.0
|
C12
|
B:E4Z201
|
4.1
|
21.6
|
1.0
|
CB
|
B:GLU26
|
4.1
|
33.4
|
1.0
|
CD1
|
B:PHE24
|
4.2
|
25.8
|
1.0
|
CA
|
B:PHE24
|
4.4
|
25.9
|
1.0
|
CD
|
B:GLU26
|
4.5
|
35.0
|
1.0
|
CE
|
B:MET34
|
4.6
|
27.4
|
1.0
|
O
|
B:PHE24
|
4.6
|
29.7
|
1.0
|
OE2
|
B:GLU26
|
4.7
|
36.0
|
1.0
|
CA
|
B:MET21
|
4.7
|
24.0
|
1.0
|
O
|
B:MET21
|
4.7
|
23.6
|
1.0
|
C
|
B:PHE24
|
4.8
|
28.3
|
1.0
|
C14
|
B:E4Z201
|
4.8
|
20.3
|
1.0
|
O
|
B:THR20
|
4.9
|
21.0
|
1.0
|
CE2
|
B:PHE24
|
5.0
|
24.0
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 6fs8
Go back to
Fluorine Binding Sites List in 6fs8
Fluorine binding site 2 out
of 4 in the Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F201
b:24.1
occ:1.00
|
F1
|
B:E4Z201
|
0.0
|
24.1
|
1.0
|
C24
|
B:E4Z201
|
1.3
|
23.6
|
1.0
|
C23
|
B:E4Z201
|
2.3
|
23.8
|
1.0
|
C13
|
B:E4Z201
|
2.4
|
21.9
|
1.0
|
F2
|
B:E4Z201
|
2.6
|
26.8
|
1.0
|
C14
|
B:E4Z201
|
2.8
|
20.3
|
1.0
|
CE
|
B:MET34
|
3.3
|
27.4
|
1.0
|
SD
|
B:MET34
|
3.4
|
28.2
|
1.0
|
C22
|
B:E4Z201
|
3.6
|
24.1
|
1.0
|
C12
|
B:E4Z201
|
3.6
|
21.6
|
1.0
|
S3
|
B:E4Z201
|
3.9
|
22.1
|
1.0
|
C21
|
B:E4Z201
|
4.1
|
23.6
|
1.0
|
CG
|
B:MET34
|
4.5
|
25.7
|
1.0
|
CG
|
B:GLU26
|
4.7
|
33.2
|
1.0
|
OE2
|
B:GLU26
|
4.9
|
36.0
|
1.0
|
C11
|
B:E4Z201
|
4.9
|
19.5
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 6fs8
Go back to
Fluorine Binding Sites List in 6fs8
Fluorine binding site 3 out
of 4 in the Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F201
b:23.7
occ:1.00
|
F2
|
A:E4Z201
|
0.0
|
23.7
|
1.0
|
C23
|
A:E4Z201
|
1.3
|
20.5
|
1.0
|
C24
|
A:E4Z201
|
2.4
|
20.0
|
1.0
|
C22
|
A:E4Z201
|
2.4
|
19.7
|
1.0
|
F1
|
A:E4Z201
|
2.7
|
21.1
|
1.0
|
CB
|
A:PHE24
|
3.1
|
20.0
|
1.0
|
OE1
|
A:GLU26
|
3.1
|
35.7
|
0.6
|
CG
|
A:GLU26
|
3.2
|
18.8
|
0.4
|
C21
|
A:E4Z201
|
3.6
|
18.7
|
1.0
|
C13
|
A:E4Z201
|
3.7
|
17.7
|
1.0
|
CG
|
A:PHE24
|
3.7
|
19.8
|
1.0
|
SD
|
A:MET34
|
3.7
|
20.8
|
1.0
|
CB
|
A:GLU26
|
3.8
|
20.5
|
0.4
|
CD
|
A:GLU26
|
3.9
|
33.3
|
0.6
|
CB
|
A:GLU26
|
3.9
|
29.7
|
0.6
|
CA
|
A:MET21
|
4.1
|
17.8
|
1.0
|
CD1
|
A:PHE24
|
4.1
|
19.6
|
1.0
|
C12
|
A:E4Z201
|
4.1
|
17.3
|
1.0
|
CG
|
A:GLU26
|
4.2
|
32.6
|
0.6
|
O
|
A:MET21
|
4.2
|
18.1
|
1.0
|
CD2
|
A:PHE24
|
4.5
|
20.9
|
1.0
|
CA
|
A:PHE24
|
4.5
|
20.3
|
1.0
|
O
|
A:THR20
|
4.5
|
17.7
|
1.0
|
CE
|
A:MET34
|
4.5
|
21.9
|
1.0
|
CG
|
A:MET21
|
4.6
|
19.7
|
1.0
|
CD
|
A:GLU26
|
4.6
|
17.9
|
0.4
|
C
|
A:MET21
|
4.7
|
18.1
|
1.0
|
O
|
A:PHE24
|
4.7
|
22.1
|
1.0
|
CB
|
A:MET21
|
4.7
|
18.9
|
1.0
|
C
|
A:PHE24
|
4.8
|
21.0
|
1.0
|
OE2
|
A:GLU26
|
4.8
|
32.2
|
0.6
|
CD1
|
A:ILE38
|
4.8
|
15.5
|
1.0
|
N
|
A:MET21
|
4.9
|
17.4
|
1.0
|
N
|
A:GLU26
|
4.9
|
25.6
|
0.6
|
C14
|
A:E4Z201
|
4.9
|
18.6
|
1.0
|
N
|
A:GLU26
|
4.9
|
22.7
|
0.4
|
N
|
A:PHE24
|
5.0
|
18.6
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 6fs8
Go back to
Fluorine Binding Sites List in 6fs8
Fluorine binding site 4 out
of 4 in the Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Influenza B/Memphis/13/03 Endonuclease with Bound Inhibitor, Baloxavir Acid (Bxa) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F201
b:21.1
occ:1.00
|
F1
|
A:E4Z201
|
0.0
|
21.1
|
1.0
|
C24
|
A:E4Z201
|
1.3
|
20.0
|
1.0
|
C23
|
A:E4Z201
|
2.3
|
20.5
|
1.0
|
C13
|
A:E4Z201
|
2.4
|
17.7
|
1.0
|
F2
|
A:E4Z201
|
2.7
|
23.7
|
1.0
|
C14
|
A:E4Z201
|
2.9
|
18.6
|
1.0
|
CE
|
A:MET34
|
3.0
|
21.9
|
1.0
|
SD
|
A:MET34
|
3.3
|
20.8
|
1.0
|
C22
|
A:E4Z201
|
3.6
|
19.7
|
1.0
|
C12
|
A:E4Z201
|
3.7
|
17.3
|
1.0
|
OE1
|
A:GLU26
|
3.9
|
35.7
|
0.6
|
S3
|
A:E4Z201
|
4.0
|
19.8
|
1.0
|
C21
|
A:E4Z201
|
4.1
|
18.7
|
1.0
|
CD
|
A:GLU26
|
4.2
|
33.3
|
0.6
|
CG
|
A:GLU26
|
4.2
|
18.8
|
0.4
|
CG
|
A:MET34
|
4.4
|
19.4
|
1.0
|
OE2
|
A:GLU26
|
4.5
|
32.2
|
0.6
|
CG
|
A:GLU26
|
4.8
|
32.6
|
0.6
|
CD
|
A:GLU26
|
4.9
|
17.9
|
0.4
|
C11
|
A:E4Z201
|
4.9
|
16.3
|
1.0
|
|
Reference:
S.Omoto,
V.Speranzini,
T.Hashimoto,
T.Noshi,
H.Yamaguchi,
M.Kawai,
K.Kawaguchi,
T.Uehara,
T.Shishido,
A.Naito,
S.Cusack.
Characterization of Influenza Virus Variants Induced By Treatment with the Endonuclease Inhibitor Baloxavir Marboxil. Sci Rep V. 8 9633 2018.
ISSN: ESSN 2045-2322
PubMed: 29941893
DOI: 10.1038/S41598-018-27890-4
Page generated: Thu Aug 1 20:13:25 2024
|